Jamieson Wellness (TSE:JWEL) had its price objective trimmed by TD Securities from C$31.00 to C$27.00 in a research note released on Friday, November 23rd. The firm currently has a buy rating on the stock.
A number of other research firms also recently issued reports on JWEL. National Bank Financial cut their target price on shares of Jamieson Wellness from C$29.00 to C$27.00 and set an outperform rating on the stock in a research report on Wednesday, November 7th. BMO Capital Markets downgraded shares of Jamieson Wellness from an outperform rating to a market perform rating and cut their target price for the company from C$28.00 to C$24.00 in a research report on Wednesday, November 7th. Royal Bank of Canada upped their target price on shares of Jamieson Wellness from C$26.00 to C$27.00 and gave the company an outperform rating in a research report on Wednesday, August 1st. Finally, Canaccord Genuity cut their price target on shares of Jamieson Wellness from C$28.00 to C$26.00 in a research report on Wednesday, November 7th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of C$26.03.
TSE JWEL traded down C$0.89 on Friday, hitting C$21.28. 72,100 shares of the company were exchanged, compared to its average volume of 52,494. The company has a current ratio of 1.72, a quick ratio of 0.81 and a debt-to-equity ratio of 74.86. Jamieson Wellness has a 1-year low of C$17.15 and a 1-year high of C$27.88.
In other Jamieson Wellness news, insider Christopher Snowden bought 15,623 shares of the stock in a transaction that occurred on Tuesday, November 13th. The stock was acquired at an average cost of C$20.00 per share, with a total value of C$312,460.00. Also, Director David Michael Williams bought 10,000 shares of the stock in a transaction that occurred on Monday, November 26th. The shares were acquired at an average cost of C$21.39 per share, with a total value of C$213,900.00. Insiders purchased a total of 27,773 shares of company stock worth $570,593 over the last quarter.
Jamieson Wellness Company Profile
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products worldwide. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and LVHS brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Featured Article: How Do Tariffs Affect Trade Balances?
Receive News & Ratings for Jamieson Wellness Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Jamieson Wellness and related companies with MarketBeat.com’s FREE daily email newsletter.
Originaly posted on Source by